As of 2026-04-07, the Fair Value of EyePoint Pharmaceuticals Inc (EYPT) is -13.90 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 13.11 USD, the upside of EyePoint Pharmaceuticals Inc is -206.04%.
With the market price of 13.11 USD and our fair value calculation, EyePoint Pharmaceuticals Inc (EYPT) is not a good investment. Investing in EYPT stocks now will result in a potential loss of 206.04%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -58.42 | -102.25 | -70.79 | -130.87 | -231.96 | -118.86 |
| YoY growth | -28.71% | -75.03% | 30.76% | -84.86% | -77.25% | -47.01% |
| Market Cap (mil) | 1,093.77 |
| P/E | |
| Forward P/E |
| EPS | -2.78 |
| Avg earnings growth rate | -47.01% |
| TTM earnings | -231.96 |